Table 2 (abstract A80). Medications at baseline for patients with DLE (Skin-Limited and SLE). Topical steroids and hydroxychloroquine were most frequently prescribed
Medication | N, (%) |
|---|---|
Topical steroids | 132 (65%) |
Hydroxychloroquine | 118 (58%) |
Other immunomodulatory medications | 59 (29%) |
• Prednisone/Methylprednisolone | 46 (22%) |
• Mycophenolate mofetil | 16 (8%) |
• Rituximab | 5 (2%) |
• Methotrexate | 4 (2%) |
• Dapsone | 4 (2%) |
• Azathioprine | 4 (2%) |
• Quinacrine | 1 (0.5%) |
• Thalidomide | 1 (0.5%) |
Topical calcineurin inhibitors | 40 (20%) |
None | 13 (6%) |